Home / Michael J. Cerminaro
Michael J. Cerminaro
Mr. Cerminaro leads the capital formation process while sharing the strategic management for the Company with Mr. Woodall. He is responsible for legal, finance & accounting, sales & marketing, and manufacturing activities of the company.
He has extensive experience in early stage company development, as well as, private equity leadership. Mr. Cerminaro is the founder of the Cerminaro Group, a private equity advisory and principal investment group, where he serves as the President and CEO.
He was a co-founder of Sound Harbor Partners, a private credit management firm with over $2 billion of assets under management that he successfully exited. He was one of the original senior partners who built and developed BlackRock Private Equity Partners (PEP), a $5 billion global private equity investment platform. While at BlackRock PEP he served as the Chairman of the Investment Operating Committee, Chairman of the Investment Valuation Committee, and as a member of the Management Committee.
He was also a co-founding member of the private equity advisory platforms of UBS Warburg and Bank of America Capital Markets. Mr. Cerminaro has been an angel investor in numerous start-ups and has served on the board of directors for a number of early stage companies as well as the advisory boards of several leading private equity firms in the US and in Europe.
He received his undergraduate degree with a double major in Economics and Business Administration from the State University of New York at Brockport and received an MBA in Finance from the Mays Business School at Texas A&M University.
Opportunity
“ It’s an opportunity for us to do something that’s going to have a materially positive impact on the healthcare system and help people.”
- Mike Cerminaro
President and CEO
Available Now:
Need more details? Contact us.
We are here to assist. Contact us by phone, email or via our social media channels.
The BASHIR™
Endovascular Catheter is intended for the controlled and selective infusion of physician specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.
.jpg)
The BASHIR™ Plus
Endovascular Catheter
is intended for the controlled and selective infusion of physician specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.
The BASHIR™ +30
Endovascular Catheter
is intended for the controlled and selective infusion of physician specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.
The BASHIR™ N-X
Endovascular Catheter is a device intended for the localized infusion of physician-specified fluids, into the peripheral vasculature, including the pulmonary arteries.
The BASHIR™ +10
Endovascular Catheter
is intended for the controlled and selective infusion of physician specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.
The BASHIR™ +40
Endovascular Catheter
is intended for the controlled and selective infusion of physician specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.
The BASHIR™ S-B
Endovascular Catheter is a device intended for the localized infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature.
The BASHIR™ +20
Endovascular Catheter
is intended for the controlled and selective infusion of physician specified fluids, including thrombolytics, into the peripheral vasculature, enabling the restoration of blood flow in patients with venous thrombus.